Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
Restoring ion concentrations to improve outcome after hemorrhagic stroke
FY 2018-19
Summary
Intracerebral hemorrhage (ICH), a bleed in the brain, is a devastating disease. This bleed damages tissue and dramatically disrupts brain function, leading to death or disability. For those who survive, there is no treatment to improve recovery, which is often limited. One factor that limits the brain’s ability to recover is the brain environment itself. Even weeks after ICH, important ions such as sodium and chloride are not present in the correct concentrations. There are many factors that lead to ion imbalances, including increased ion channel expression. Neurons communicate using these ions, and not having them in proper concentrations affects the ability to function properly. Restoring these ions to the right amounts may improve the brain’s repair processes. Previous research has shown that rehabilitation, a common treatment after ICH, restores chloride levels and reduces damage. I will use a rat model of ICH to investigate a pharmacological approach to restoring ion levels. This will further characterize the relationship between ion levels and outcome and to test a potential therapy for ICH patients. Glibenclamide, a drug that blocks sodium movement into cells, will be used to restore sodium concentrations. This drug acts on a sodium channel that is only expressed after brain injury, including ICH. By blocking this channel, I hope to limit sodium increases and restore the brain environment to improve recovery processes. After inducing an ICH in rats, we will give glibenclamide at safe doses during the period of injury. We will assess the impact of glibenclamide on brain injury, behavioural outcome, and ion concentrations. This will allow us to determine if fixing the ion imbalances improves recovery after ICH. If it does, this is a promising target for patients.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
406263
Name
Wilkinson Cassandra M
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Restoring ion concentrations to improve outcome after hemorrhagic stroke
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Animal Model; Blood-Brain Barrier; Brain Edema; Glibenclamide; Intracerebral Hemorrhage; Ion Homeostasis; Neuroplasticity; Neuroprotection; Stroke; Translational
Abstract
Intracerebral hemorrhage (ICH), a bleed in the brain, is a devastating disease. This bleed damages tissue and dramatically disrupts brain function, leading to death or disability. For those who survive, there is no treatment to improve recovery, which is often limited. One factor that limits the brain’s ability to recover is the brain environment itself. Even weeks after ICH, important ions such as sodium and chloride are not present in the correct concentrations. There are many factors that lead to ion imbalances, including increased ion channel expression. Neurons communicate using these ions, and not having them in proper concentrations affects the ability to function properly. Restoring these ions to the right amounts may improve the brain’s repair processes. Previous research has shown that rehabilitation, a common treatment after ICH, restores chloride levels and reduces damage. I will use a rat model of ICH to investigate a pharmacological approach to restoring ion levels. This will further characterize the relationship between ion levels and outcome and to test a potential therapy for ICH patients. Glibenclamide, a drug that blocks sodium movement into cells, will be used to restore sodium concentrations. This drug acts on a sodium channel that is only expressed after brain injury, including ICH. By blocking this channel, I hope to limit sodium increases and restore the brain environment to improve recovery processes. After inducing an ICH in rats, we will give glibenclamide at safe doses during the period of injury. We will assess the impact of glibenclamide on brain injury, behavioural outcome, and ion concentrations. This will allow us to determine if fixing the ion imbalances improves recovery after ICH. If it does, this is a promising target for patients.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wilkinson, Cassandra M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~